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Abstract
Background: Food allergies are generally associated with gastrointestinal upset, but in many
patients systemic reactions occur. However, the systemic effects of food allergies are poorly
understood in experimental animals, which also offer the opportunity to explore the actions of
anti-allergic drugs. The tripeptide D-phenylalanine-D-glutamate-Glycine (feG), which potentially
alleviates the symptoms of systemic anaphylactic reactions, was tested to determine if it also
reduced systemic inflammatory responses provoked by a gastric allergic reaction.
Results: Optimal inhibition of intestinal anaphylaxis was obtained when 100 µg/kg of feG was given
20 min before the rats were challenged with antigen. The increase in total circulating neutrophils
and accumulation of neutrophils in the heart, developing 3 h and 24 h, respectively, after antigen
challenge were reduced by both feG and dexamethasone. Both anti-inflammatory agents reduced
the increase in vascular permeability induced by antigen in the intestine and the peripheral skin
(pinna), albeit with different time courses. Dexamethasone prevented increases in vascular
permeability when given 12 h before antigen challenge, whereas feG was effective when given 20
min before ingestion of antigen. The tripeptide prevented the anaphylaxis induced up regulation of
specific antibody binding of a cell adhesion molecule related to neutrophil activation, namely
CD49d (α 4 integrin).
Conclusions:  Aside from showing that intestinal anaphylaxis produces significant systemic
inflammatory responses in non-intestinal tissues, our results indicate that the tripeptide feG is a
potent inhibitor of extra-gastrointestinal allergic reactions preventing both acute (30 min) and
chronic (3 h or greater) inflammatory responses.
Background
Type 1 or IgE-mediated allergic reactions play an impor-
tant role in food sensitivity reactions [1]. These reactions
affect gut motility [2–4], absorption and secretion by the
intestinal epithelium [5–7], and enteric as well as central
nervous system function [8–11]. Systemic anaphylactic re-
actions, initiated outside the gastrointestinal tract, have
pronounced impact on its integrity and function [12,13],
but few studies have determined the impact of intestinal
anaphylaxis on other tissues and organs.
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Figure 1
White blood cells after intestinal anaphylaxis. Time course of total cells (A) and neutrophils (B) in heart blood of oval-
bumin sensitized rats receiving either saline (Control), antigen p.o. (Ag), feG (100 µg/kg, p.o.) and antigen (feG + Ag), or dex-
amethasone (4 mg/kg; i.p.) & antigen (Dex + Ag). Number of animals = 4 to 6. Significance (P < 0.05): * greater than Control; τ
less than Ag at time indicated; # less than Control;   greater than Ag and Ag + feG at times indicated.
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In experimental animals minor and infrequent respiratory
and cardiovascular effects after oral challenge with anti-
gen in sensitized Brown Norway rats were reported [14].
However, systemic anaphylactic reactions involving the
cutaneous, respiratory and cardiovascular systems follow-
ing ingestion of food are fairly common in humans as
they occur with 10–30% of sensitized individuals [15–
18]. In our own studies, where the presence of diarrhea
was used as a clinical sign of intestinal anaphylaxis in oral-
ly challenged ovalbumin sensitized Hooded-Lister rats
[19–21], frequent piloerection was observed. This obser-
vation led us to suspect that systemic effects of intestinal
anaphylaxis may be subtler than expected, and we decided
to examine the hematological and vascular permeability
changes associated with intestinal anaphylaxis. In these
earlier studies we described protective effects of a hep-
tapeptide, submandibular gland peptide-T (SGP-T) and
its associated fragments, the tripeptide FEG and its D-iso-
meric form feG, on gastrointestinal function with orally
administered antigen [19,20,22].
The present investigations examine systemic effects of oral
antigen challenge of ovalbumin sensitized Hooded-Lister
rats. The circulating neutrophilia, increases in vascular
permeability, neutrophil accumulation in the heart and
activation of cell adhesion molecules caused by oral inges-
tion of antigen were significantly reduced by the tripep-
tide – feG.
Results
Blood cell counts
Changes in total white blood cell counts were only seen at
3 h after antigen challenge (Figure 1A). A significant in-
crease was observed in rats receiving only antigen (7.8 ±
0.5 ×  106 cells/mL), relative to sensitized control rats (5.6
± 0.4 ×  106 cells/mL). This increase was prevented by the
treatment with feG (6.0 ± 0.55 ×  106 cells/mL). The rats
treated with dexamethasone experienced a sharp drop in
their total white blood cell counts (3.2 ± 0.4 ×  106 cells/
mL) at 3 h after antigen challenge. At this time a signifi-
cant increase in circulating neutrophils was seen in the
OA-challenged animals (Figure 1B). This increase in circu-
lating neutrophils was prevented by treatment with feG
and dexamethasone, although at 24 h neutrophil number
increased more than five fold from 6.0 ± 0.5 (× 105) cells/
mL to 33.5 ± 5.2 (× 105) cells/mL in the dexamethasone,
but not feG, treated rats. No changes were seen in the
number of circulating lymphocytes at any of the time
points sampled (not shown).
Hematocrit
Intragastric challenge with antigen did not modify hema-
tocrit, relative to unchallenged sensitized rats (40.4 ±
0.8%), at any of the time points tested. However, rats
treated with feG experienced a small decrease in hemat-
ocrit at 0.5 h after antigen challenge (39.1 ± 0.5%). In con-
trast, dexamethasone treated rats had significantly higher
hematocrit values, than the other 3 groups of animals, at
0.5 h (45.6 ± 0.4%) and 24 h (45.5 ± 1.8%), but not at 3
h (40.2 ± 0.6%) post-challenge.
Bone marrow counts
The effect of intestinal anaphylaxis and the treatment with
feG on bone marrow counts was examined at 3 h after an-
tigen challenge. In control-sensitized rats the bone mar-
row was 13.6 ± 1.2 (× 106 cells), and this was not
significantly altered by either antigen alone 11.0 ± 1.4
(× 106 cells) or in feG-treated challenged rats 11.1 ± 1.0
(× 106 cells).
Vascular permeability changes
The acute (30 min) changes in vascular permeability in-
duced by antigen in the pinna, jejunum and duodenum
was prevented by feG, but not by dexamethasone, when
these compounds were given 20 min before antigen chal-
lenge (Table 1). On the other hand dexamethasone pre-
vented the changes in vascular permeability provoked by
antigen when given 12 h before initiation of the allergic
reaction, whereas this prior treatment with feG was inef-
fective. Antigen challenge alone or in drug treated rats did
not affect vascular permeability in the heart or the trachea
(not shown).
Leukocyte infiltration into the heart
Leukocyte infiltration into the heart, measured with the
MPO assay, increased ~75% in OA challenged animals
(0.69 ± 0.09 units/mg tissue) relative to controls (0.40 ±
0.05 units/mg tissue) at 24 h after antigen challenge (Fig-
ure 2). Treatment with feG or dexamethasone at the time
of antigen challenge prevented this accumulation of neu-
trophils in the myocardium. Interestingly, at 3 h after an-
tigen challenge the MPO content of the heart decreased,
relative to control animals, in both feG and dexametha-
sone treated rats. Only at 0.5 h were significant changes in
tissue MPO content of the lung seen, with feG treated rats
exhibiting a decrease from 1.01 ± 0.08 units/mg tissue to
0.79 ± 0.08 units/mg tissue. On the other hand, at 24 h af-
ter antigen challenge dexamethasone treatment resulted
in a significant increase in MPO activity to 1.55 ± 0.03
units/mg of lung tissue.
Cell adhesion marker expression
To investigate a relationship between the effects of feG on
CD11b and CD49d expression, these antigens were meas-
ured on the surface of peritoneal neutrophils isolated
from sensitized rats 24 h after exposure to antigen and
treatment with feG or the saline vehicle. The inhibitory ef-
fect of feG, seen on basal expression of CD11b was not
observed in rats that had received an antigen challenge 24
h previously (Figure 3). CD49d was not modified by sen-BMC Physiology 2002, 2 http://www.biomedcentral.com/1472-6793/2/13
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sitization or antigen challenge, but feG treatment signifi-
cantly reduced the expression of this adhesion molecule
in OA-exposed animals to values that were 50% of those
measured in rats receiving antigen only.
Interstitial cells in intestinal smooth muscle
Twenty-four hours after the administration of oral antigen
a decreased number of cells expressed the CD18 marker in
the smooth muscle of the jejunum (Table 2). This reduc-
tion was partially reversed in animals receiving feG. Two
morphological distinct leukocytes that stained for ED9
(LPS receptor) could be identified. One type was round
and displayed the typical nucleus structure of neutrophils,
and the other type had the stellate shape of interstitial
macrophages. The number of macrophage-like leukocytes
binding ED9 antibody was not affected by antigen chal-
lenge, whereas there was a 70% decrease in the number of
ED9+ neutrophils. This decrease was significantly reduced
by feG.
Discussion
Aside from the general malaise and gastrointestinal dis-
comfort that food allergic individuals experience, pro-
nounced respiratory and cardiovascular effects resulting
in serious discomfort and requiring medical intervention
are uncommon, but when they occur a medical emergen-
cy may ensue [15,17]. As with humans, severe systemic re-
actions in animal models of food allergy are uncommon,
although in a rat model, the orally sensitized and -chal-
lenged Brown Norway rats, some animals exhibited mi-
nor respiratory and cardiovascular changes [14]. Oral
antigen challenge of the adjuvant-primed intraperitoneal-
ly sensitized Hooded-Lister rats also produces both intes-
tinal and systemic reactions [3,4]. These two animal
models of sensitization can produce an IgE-dependent in-
testinal allergic reaction yielding an anaphylaxis-depend-
ent increase in intestinal permeability [5,14]. A
distinguishing feature of the Hooded-Lister rat model is
diarrhea; a clinical response that has not been reported in
other animal models of intestinal allergy.
Our results indicate that gastrointestinal anaphylaxis re-
sults in significant systemic effects. Changes in vascular
permeability occurred with 0.5 h, peripheral blood neu-
trophilia appeared at 3 h, and significant accumulation of
neutrophils in the heart was seen at 24 h after antigen
challenge. Several factors could contribute to the extra-in-
testinal manifestations of intestinal allergic reactions, in-
cluding the vascular leak of antigen [23] activation of
peripheral mast cells [14], appearance of intestinal mast
cell mediators in the blood [21], and/or a neurogenic re-
flex [9]. The absence of an increased vascular leak in the
trachea following gastric administration of antigen (Table
2), contrasts with the effects of intravenous [24] or air-
ways [25,26] application of the sensitizing allergen. These
differences may relate to the species used, as pulmonary
allergic reactions have never been reported for Hooded-
Lister rats. As seen in other species of rats, even with intra-
venous challenge with antigen [24,13], we found no vas-
cular leak into the heart with an anaphylactic reaction.
Although anaphylactic reactions induced by intraperito-
neal [27] or intravenous [28] administration of antigen
are generally accompanied by marked and rapid hemo-
concentration, the intestinal hypersensitivity reaction did
not produce significant modification of hematocrit, even
with the observed increases in vascular permeability. This
absence of hemoconcentration indicates a much less se-
vere systemic anaphylaxis following oral challenge with
antigen than occurs when the antigen is applied directly
into the circulation. Nonetheless, the delayed (3 h) blood
neutrophilia (Figure 1) seen after oral antigen also indi-
cates that intestinal anaphylaxis has hematological conse-
quences. Circulating neutrophilia may be a hallmark of
anaphylactic reactions as they are also observed in mon-
Table 1: Anaphylaxis induced vascular permeability. Effects of feG and dexamathasone (Dex) on vascular permeability changes induced 
by oral challenge with OA (100 mg/kg). The animals were treated with feG or Dex at 30 min or 12 h before antigen challenge.
No Antigen Antigen
Tissue Control Saline feG -30 min Dex-30 min feG -12 h Dex -12 h
Pinna 2.4 ± 0.2a 3.2 ± 0.2* 2.1 ± 0.5# 3.3 ± 0.4* 2.9 ± 0.3 2.2 ± 0.3#
Jejunum 16.6 ± 0.9 32.2 ± 4.3* 15.8 ± 0.8# ND 20.5 ± 2.3 17.6 ± 2.8#
Ileum 19.0 ± 1.4 27.8 ± 3.4* 16.3 ± 1.3# 22.8 ± 0.8 23.7 ± 1.9 17.2 ± 2.3#
a = Values presented as mean ± SEM. N values = 4. Significance: P < 0.05; * greater than Control; # less than Saline (antigen only).BMC Physiology 2002, 2 http://www.biomedcentral.com/1472-6793/2/13
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Figure 2
Neutrophil accumulation in heart and lungs. Time course of myeloperoxidase content of the heart (A) and lungs (B) of
ovalbumin sensitized rats receiving either saline (Control), antigen p.o. (Ag), feG (100 µg/kg, p.o.) and antigen (feG + Ag), or
dexamethasone (4 mg/kg; i.p.) & antigen (Dex + Ag). Number of animals = 4 to 6. Significance (P < 0.05)): # less than Control;
τ  less than Ag at time indicated;   greater than Ag and Ag + feG at times indicated.
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keys [31], and in rats using different methods of sensitiza-
tion and routes of antigen administration [29,30]. A
notable exception is the neutropenia seen in guinea pigs
[32].
Anaphylaxis has important effects on neutrophils as ex-
emplified by their early (3 h) loss, but late (24 h) increase
in the heart (Figure 2), and decrease in intestinal smooth
muscle (Table 1). This early loss of neutrophils from the
heart could represent an allergy-mediated degranulation
of the tissue resident neutrophils, and subsequent degra-
dation of the enzyme, whereas the late-phase neutrophilia
(24 h) reflects a net migration of cells into the myocar-
dium consequent to action of release of mediators of ana-
phylaxis. The reduced number of ED9+ neutrophils in
intestinal muscle was also seen with rats receiving intra-
peritoneal lipopolysaccharide [33], and may represent a
loss of the ED9 cell marker with a phenotypic change to
the interstitial neutrophils [34] following the inflamma-
tory insult. Although direct injury to the heart, such as oc-
curs with ischemia-reperfusion injury [35] and other
forms of cardiomyopathy [36], are accompanied by pro-
nounced neutrophil influx into the damaged tissue, the
current report is the first description of anaphylaxis in-
duced accumulation of neutrophils in the heart. Left ven-
tricular contraction is compromised with systemic
anaphylaxis [37], and our results suggest that mild ana-
phylactic reactions, as may occur with a gastrointestinal
reaction, could have deleterious, and long term, effects on
the heart. The accumulation of neutrophils in the myocar-
dium may in part be reduced by the peptide feG conse-
quent to decreased expression of α 4 integrin (CD49d)
from neutrophils (Figure 3), since the adherence of neu-
trophils to cardiac tissue is mediated primarily by α 4β 1
integrin [38,39].
This action on CD49d indicates that a reduction in cell ad-
hesion by interfering with integrins may be an important
component of feG's anti-inflammatory effects directly
upon inflammatory leukocytes. The prevention. by feG, of
the decrease in resident intestinal neutrophils, blood neu-
trophilia and vascular leak concord with this proposed
mechanism since these three processes are integrin de-
pendent [40–42]. In several respects feG is distinguished
from anti-inflammatory steroids, especially with regards
to a shorter onset and duration of action, and an absence
of some of the pro-inflammatory effects, such as circulat-
ing and pulmonary neutrophilia. These differences in
anti-inflammatory actions between feG and dexametha-
sone probably relate to the time delay of 4 h to 12 h asso-
ciated with the steroids actions as a transcription inhibitor
Figure 3
Cell adhesion molecules on peritoneal neutrophils. Changes in mean flourescence intensity (MFI) for CD11b and
CD49d on peritoneal neutrophils in sensitized rats that were either untreated (Control), received feG alone (feG), only anti-
gen (Ag) or both antigen and feG (Ag + feG). Significance: (P < 0.05): # less than Control; * greater than Control; τ  less than Ag
at time indicated.BMC Physiology 2002, 2 http://www.biomedcentral.com/1472-6793/2/13
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[43], which, however, eventually results in reduced in-
tegrin expression on leukocytes [44].
Food allergy in humans frequently results in digestive, cu-
taneous, respiratory and cardiovascular reactions [15–18],
however detection of allergen-induced cardiac inflamma-
tion in humans would be difficult, and to our knowledge
food allergen induced cardiac inflammation in humans
has never been reported. However, co-inflammatory in-
sults, such as food allergy, that cause activation of cardiac
resident mast cells or enhance inflammatory cell infiltra-
tion should be avoided in patients with an ongoing in-
flammation of the heart, i.e. myocarditis, dilated
cardiomyopathy, ischemic cardiac injury and unstable an-
gina [35,36,45,46]. The utility of feG in treating allergen-
induced inflammations in humans has not been tested,
and if such a use was contemplated the peptide would
probably be more useful in reducing the inflammation
that develops during the later-phases of the allergic reac-
tions as seen herein and other studies [19,33].
Conclusions
Unlike asthmatic reactions, for which several therapeutic
agents are available, the continuous use of anti-anaphy-
lactic drugs to manage food allergies is a therapeutic op-
tion that neither widely practiced nor promoted. The
present study suggests that another component to the
management of food allergies is to reduce the severity of
systemic effects. In this regard the tripeptide feG was
found to reduce the early and delayed systemic anaphy-
laxis provoked by oral antigen and this peptide could con-
ceivably be taken after exposure to oral antigen and
thereby limit the severity of delayed systemic reactions.
Materials and Methods
Animals and surgical procedures
All experiments described in this study were approved by
The University of Calgary, Animal Care Committee in ac-
cordance with the guidelines of the Canadian Council on
Animal Care. Male Hooded-Lister rats, weighing 150–170
g, were raised at the Life and Environmental Sciences An-
imal Resource Centre, The University of Calgary. The rats
were housed under controlled lighting conditions (lights
on from 7:00 H to 19:00 H), and provided with food and
water ad libitum. All surgical procedures were performed
with the animal under halothane anesthesia.
Sensitization to antigen and determination of antibody tit-
er
The rats were sensitized by intraperitoneal injection of 10
µg of the antigen chicken ovalbumin (OA) (Grade V, Sig-
ma Chemical Co., St. Louis, MO) and 10 mg of aluminum
hydroxide (Al(OH)3) adjuvant in saline. This sensitiza-
tion protocol results in an IgE-dependent anaphylaxis
[47], and blood anti-OA IgE antibody titer was measured
by passive cutaneous anaphylaxis 10 days after sensitiza-
tion [3] using a small aliquot of blood (500 µl) obtained
by cardiac puncture. The serum was then diluted serially
(1:8 to 1:64) and 300 µl of each sample was injected into
the shaved back of Sprague-Dawley rats. After 48 h, the
rats were challenged with an intracardiac injection of a so-
lution containing 2.5 mg of Evan's blue and 5 mg of OA
in a total volume of 2.5 mL. Evan's blue extravasation was
determined at the injection site, and a serum anti-OA an-
tibody titer of 1:64 was required for an animal to be in-
cluded in the experiments.
Antigen challenge and drug treatments
Four different groups of sensitized rats received one of the
following treatments: (1) control animals received 0.9%
saline only; (2) OA-challenged rats received 100 mg/kg of
OA in 0.9% saline; (3) feG (Core Laboratories, Queen's
University, Kingston, ON) treated rats received 100 µg/kg
of the peptide and antigen; and (4) dexamathasone treat-
ed rats received 4 mg/kg of Azium (Schering, Point Claire,
QC) intraperitoneally.
Circulating leukocyte and bone marrow cell counts
Under halothane anesthesia whole blood (200 µl) was
drawn by cardiac puncture at 0.5, 3 and 24 h after antigen
challenge. Total leukocyte counts were determined using
a Unopette microcollection system (Becton Dickinson,
Franklin Lakes, NJ) and Hylite hemocytometer (Hauser
Scientific, Boulder, CO). Another sample was used to pre-
pare blood smears for microscopic leukocyte differentia-
tion using a Giemsa stain. The hematocrit was determined
with a microcapillary centrifuge.
The animals were killed with an overdose of sodium
pentobarbital (MTC Pharmaceuticals, Cambridge, ON).
The right femur bone marrow was eluted with 10 mL of
phosphate buffered saline (PBS) and leukocyte counts
were determined using a hemocytometer. The PBS had the
following composition (mM): NaCl (137), KCl (2.7),
Na2HPO4 (8.1), KH2PO4 (1.47), CaCl2 (1.19,) MgCl2
(0.54), glucose (7.5), pH (7.4).
Measurement of plasma extravasastion
The rats were anesthetized with halothane and injected
with Evans Blue (20 mg/kg; Sigma) in 0.9% saline via car-
diac puncture, and 10 min later they were orally chal-
lenged with OA and the drugs feG and dexamethasone
were administered. Two other groups of rats were treated
with feG or dexamethasone 12 hours before the OA chal-
lenge. Thirty minutes later, and under halothane anesthe-
sia, the rats were perfused with 1 L/kg of PBS through the
left ventricle. Pieces of heart, trachea, pinna, jejunum, and
ileum tissue were excised, weighed, and placed in 1 mL of
formamide (Sigma) for 72 h at 20°C. The optical density
of the formamide was then read at 620 nm with a Beck-BMC Physiology 2002, 2 http://www.biomedcentral.com/1472-6793/2/13
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man DU-50 spectrophotometer (Beckman Coulter Cana-
da Inc., Mississauga, ON) and the amount of Evan's Blue
present was calculated from a standard curve.
Myeloperoxidase measurements
As a specific enzymatic marker of neutrophil infiltration
into the tissue, myeloperoxidase (MPO) activity was de-
termined in myocardial tissue and in lungs according pre-
viously described procedures [48]. Tissues (100–200 mg),
excised from anesthetized rats were homogenized (Poly-
tron homogenizer; Daigger, Vemon Hills, IL) in 0.5% hex-
adecyltrimethyl ammonium bromide (Sigma) dissolved
in 50 mM potassium phosphate buffer at pH 6.0 for 1
min. Homogenates were then centrifuged at 4°C for 15
min at 1000 g. The supernatant was collected and reacted
with 0.167 mg/mL o-dianisidine dihydrochloride (Sig-
ma) and 0.005% H2O2 in 50 mM phosphate buffer at pH
6.0. The change in absorbance was measured spectropho-
tometrically at 460 nm. One unit of MPO activity is de-
fined as the quantity of enzyme degrading 1 µmol of
peroxide/min at 25°C.
Intestinal histochemistry
Eighteen hours after allergen-challenged or saline treat-
ment mid-jejunal tissues were removed and whole
mounted with pins and fixed in paraformaldehyde for 20
min at ~150% of resting tissue length and ~250% of rest-
ing tissue diameter. After fixing, the tissues were stripped
of their mucosa, and histochemistry was performed on
the muscularis [38]. The intestinal tissues were incubated
for 24 h at 4°C with either ED9 or CD18 primary antibody
(Cedarlane, Hornby, ON) at a 1:100 dilution) followed
by three 5-min washes in PBS. The tissues were then incu-
bated with a labeled secondary antibody (goat anti-mouse
coupled to biotin) at 4°C overnight. After washing 3 times
for 5 min with PBS buffer, avidin coupled horseradish per-
oxidase was added for 30 min at room temperature. Fol-
lowing further washes diaminobenzadine (DAB –
Peroxidase Substrate Kit; Vector Laboratories, Burlingame,
CA) was added until desired staining was attained. The in-
testinal tissues were then dry mounted on chrom alum-
coated slides, cover slipped and viewed at × 200 magnifi-
cation. Counting was performed blind and the number of
labeled cells determined in four random fields of each
specimen.
Leukocyte preparation and use
Blood was collected by cardiac puncture into a 10 mL sy-
ringe from rats anesthetized with halothane. The blood
was diluted with approximately 30 mL of PMN buffer
(PBS buffer without calcium) in a 50 mL polypropylene
centrifuge tube, and spun at 300 g for 15 min at 20°C. Af-
ter the buffer was carefully decanted from the pellet, the
red blood cells were lysed (0.15 M NH4Cl) for 3 min at
room temperature. After a second spin at 200 g for 10 min
at 20°C, the supernatant was discarded and the pellet
washed with PMN buffer and spun again 200 g for 10 min
at 20°C. The supernatant was then discarded and the cells
resuspended in 1 mL of PMN buffer, and total cell number
determined using Trypan Blue exclusion on a hemocy-
tometer. Cell differentials were determined on cell smears
stained with May-Grünwald-Giemsa stain. Lymphocytes
were 68.7% of the circulating white blood cells, neu-
trophils accounted for 20.4% and monocytes were 11.0%.
To isolate peritoneal leukocytes 10 mL of 0.9% sterile sa-
line was injected intraperitoneally into halothane anes-
thetized rats and the abdomen massaged gently. After a
clean laparotomy the peritoneal fluid (7 to 10 mL) was re-
covered and placed into a 50 mL polypropylene tube and
diluted to 30 mL with PMN buffer. The cells were then
prepared as described for blood leukocytes. Of the perito-
neal cells 21.5% were neutrophils and 46.5% were macro-
phages.
Statistical analysis
Results were expressed as mean ± SEM and n is the
number of animals. Statistical significance of differences
between means was determined at p < 0.05, using, where
appropriate, one-way analysis of variance (ANOVA) with
the Student t-test applied for comparison of differences
between two means.
Table 2: Activation markers on interstitial cells. Effects of feG on staining of interstitial leukocytes in the jejunal muscle for CD18 and 
ED9 antigens.
CD18 ED9-Macro ED9-Neut
Saline – control 7.4 ± 1.7a 9.4 ± 2.6 13.1 ± 3.1
Antigen 3.3 ± 0.5* 13.5 ± 1.7 3.9 ± 0.7*
Antigen & feG 5.6 ± 1.2 11.6 ± 0.6 9.1 ± 1.1*,#
a = Values presented as mean ± SEM. N values = 4. Significance: P < 0.05; * less than saline; # greater than antigenBMC Physiology 2002, 2 http://www.biomedcentral.com/1472-6793/2/13
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CD11b, α M integrin; CD49d, α 4 integrin; feG, D-pheny-
lalanine-D-glutamate-Glycine; MPO, myeloperoxidase;
PBS, phosphate buffered saline; SGP-T, submandibular
gland peptide-T
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